Serum levels of soluble Fas ligand in patients with silicosis

di Tomokuni, A, Otsuki, T, Isozaki, Y, Kita, S, Ueki, H, Kusaka, M, Kishimoto, T, Ueki, A
Pubblicazione 1999

Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours

di TOMOKUNI, A, AIKOH, T, MATSUKI, T, ISOZAKI, Y, OTSUKI, T, KITA, S, UEKI, H, KUSAKA, M, KISHIMOTO, T, UEKI, A
Pubblicazione 1997

Soluble Fas mRNA is dominantly expressed in cases with silicosis.

di Otsuki, T, Sakaguchi, H, Tomokuni, A, Aikoh, T, Matsuki, T, Kawakami, Y, Kusaka, M, Ueki, H, Kita, S, Ueki, A
Pubblicazione 1998

Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individu...

di Ueki, A, Isozaki, Y, Tomokuni, A, Hatayama, T, Ueki, H, Kusaka, M, Shiwa, M, Arikuni, H, Takeshita, T, Morimoto, K
Pubblicazione 2002

Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients

di Otsuki, T, Tomokuni, A, Sakaguchi, H, Aikoh, T, Matsuki, T, Isozaki, Y, Hyodoh, F, Ueki, H, Kusaka, M, Kita, S, Ueki, A
Pubblicazione 2000

MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells

di Tomimaru, Y, Eguchi, H, Nagano, H, Wada, H, Tomokuni, A, Kobayashi, S, Marubashi, S, Takeda, Y, Tanemura, M, Umeshita, K, Doki, Y, Mori, M
Pubblicazione 2010

miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1

di Iwagami, Y, Eguchi, H, Nagano, H, Akita, H, Hama, N, Wada, H, Kawamoto, K, Kobayashi, S, Tomokuni, A, Tomimaru, Y, Mori, M, Doki, Y
Pubblicazione 2013